Editorial & Columns
#Dr.AnilKumarAngrish Archive
Editorial & Columns
Novartis India: Listing, Rumour to Delist and Divestment
Editorial & Columns
AYUSH Industry in India: Gaining Momentum
Editorial & Columns
India–EU FTA and Indian Pharma Industry
Editorial & Columns
Union Budget 2026-27: Impact on Pharmaceutical Sector
Editorial & Columns
Pharmaceutical Industry: Expectations from Union Budget 2026-27
Editorial & Columns
Pharma Companies Adapting to Jan Aushadhi Competition
Editorial & Columns
From Silos to Solutions: Lessons from a Pharma Alliance
Editorial & Columns
CY 2025: Performance of Pharma IPOs in India
Editorial & Columns